Clinical trial · Observational
Quality of Life After Gynacological Malignancies
Quality of Women Life After Gynacological Malignancies
NCT05692102CI-TRIAL-00063334unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Evaluate quality of life after gynaecological malignancies diagnosis and treatment
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gynecologic Cancer | Malignant Female Reproductive System Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Evaluate quality of life after gynaecological malignancies diagnosis and treatment | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Evaluate quality of life after gynaecological malignancies diagnosis and treatment
- timeFrame
- 2 years
- description
- Evaluate quality of women life after gynaecological malignancies diagnosis and treatment
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria:.patient diagnosed to have gynaecological cancers by histopathology 2.Adult from 20-70 yrs 3. willing and able to participate 4.Early stage 1-2 Exclusion Criteria: 1pre-existing psychological disorders 2.Stage 4 3.severe medical complications as cardiac pt 4.Morbid obesity BMI\<40
References
Publications (0)
Data not yet available
No reference posted for this study.